HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment.

doi:10.1111/hiv.70261

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment.

HIV medicine - 1 Sept 2026

Rauschning Dominic, Ike Arcy Marcelin Elenga, Holterhoff Johanna, Stockinger Amira, Assiana Darrel Ornelle Elion, Mapanguy Claujens Chastel Mfoutou, Mouzinga Freisnel Hermeland, Horn Carola, Suarez Isabelle, Heyn Ferdinand, Fila Diane Alexia, Banguissa Hubert, Niama Fabien Roch, Moukassa Donatien, Heger Eva, Ntoumi Francine, Lehmann Clara

Abstract excerpt

OBJECTIVES: Increasing rates of HIV-1 drug resistance (HIVDR) threaten the effectiveness of antiretroviral therapy (ART) programmes in sub-Saharan Africa, particularly among children, adolescents and young adults, who face limited treatment options. The Republic of Congo (ROC) lacks comprehensive national data on HIVDR in these vulnerable populations. The study aimed to determine the proportion of virologically...

Read the complete abstract on PubMed

Topics

Humans
HIV Infections
Drug Resistance, Viral
Female
HIV-1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Viral Load

Male

Adolescent

Congo

Young Adult

Adult

Child

Anti-HIV Agents

Treatment Outcome

CD4 Lymphocyte Count

Mutation

Prevalence

Source

Open in PubMed Open full text

Identifiers

PMID: 42216480
DOI: 10.1111/hiv.70261
PMCID: PMC13547435

Genes

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 23 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV drug resistance and treatment success in the Republic of Congo: Implications for optimized treatment.PMID 42216480Read ↗

Resistance to antiretroviral drugs in treated and drug-naive patients in the Democratic Republic of Congo.Semantic proximity Read ↗

Nationwide patterns of HIV drug resistance and high viral load in Sub-Saharan African countries.Semantic proximity Read ↗

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: A cross-sectional study.Semantic proximity Read ↗

HIV drug resistance during antiretroviral therapy scale-up in Uganda, 2012-19: a population-based, longitudinal study.Semantic proximity Read ↗

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda. A cross-sectional studySemantic proximity Read ↗

Pre-treatment HIV-1 drug resistance in antiretroviral therapy-naive adults in Eastern Africa: a systematic review and meta-analysis.Semantic proximity Read ↗

HIV-1 Antiretroviral Drug Resistance in Mozambique: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Acquired HIV-1 drug resistance to reverse transcriptase and protease inhibitors among people failing antiretroviral therapy in Cameroon and implications for future treatment options.Semantic proximity Read ↗

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read ↗

HIV-1 drug resistance and resistance testing.Semantic proximity Read ↗

Molecular Epidemiology and Trends in HIV-1 Transmitted Drug Resistance in Mozambique 1999-2018.Semantic proximity Read ↗

HIV-1 resistance mutations and genetic diversity among children failing antiretroviral treatment in five healthcare facilities in Benin, West Africa.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.